Operating Expenses
Amortization of Finite-Lived Intangible Assets
Boston Scientific Amortization of Finite-Lived Intangible Assets increased by 1.8% to $232M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $219M to $232M. Over 4 years (FY 2021 to FY 2025), Amortization of Finite-Lived Intangible Assets shows an upward trend with a 4.9% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Metric ID:
amgn_amortization_of_finite_lived_intangiblesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180M | $184M | $192M | $198M | $204M | $202M | $199M | $203M | $210M | $208M | $208M | $214M | $213M | $205M | $225M | $219M | $225M | $225M | $228M | $232M |
| QoQ Change | — | +2.2% | +4.3% | +3.1% | +3.0% | -1.0% | -1.5% | +2.0% | +3.4% | -1.0% | +0.0% | +2.9% | -0.5% | -3.8% | +9.8% | -2.7% | +2.7% | +0.0% | +1.3% | +1.8% |
| YoY Change | — | — | — | — | +13.3% | +9.8% | +3.6% | +2.5% | +2.9% | +3.0% | +4.5% | +5.4% | +1.4% | -1.4% | +8.2% | +2.3% | +5.6% | +9.8% | +1.3% | +5.9% |
Range$180M – $232M
CAGR+5.5%
Avg YoY Growth+4.9%
Median YoY Growth+4.1%
Current Streak4 quarters growth
Amortization of Finite-Lived Intangible Assets at Other Companies
Frequently Asked Questions
- What is Boston Scientific's amortization of finite-lived intangible assets?
- Boston Scientific (BSX) reported amortization of finite-lived intangible assets of $232M in Q1 2026.
- How has Boston Scientific's amortization of finite-lived intangible assets changed year-over-year?
- Boston Scientific's amortization of finite-lived intangible assets increased by 5.9% year-over-year, from $219M to $232M.
- What is the long-term trend for Boston Scientific's amortization of finite-lived intangible assets?
- Over 4 years (2021 to 2025), Boston Scientific's amortization of finite-lived intangible assets has grown at a 4.9% compound annual growth rate (CAGR), from $741M to $897M.